16
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Caspases: Conductors of the Cell Death Machinery in Lymphoma Cells

, , , , &
Pages 247-253 | Received 25 Jul 2000, Published online: 01 Jul 2009

References

  • Reed J. C. Bcl-2 family proteins: regulators of apoptosis and chemoresistance in hematologic malignancies. Seminars in Hematology 1997; 34: 9–19
  • Korsmeyer S. J., Greenberg P. D. Cancer tuning in on death programs. Current Opinion in Immunology 1998; 10: 543–544
  • Bakhshi A., Jensen J. P., Goldman P., Wright J. J., McBride O. W., Epstein A. L., Korsmeyer S. J. Cloning the chromosomal breakpoint of t(14; 18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell 1985; 41: 899–906
  • Xerri L., Bouabdallah R., Devilard E., Hassoun J., Stoppa A. -M., Birg F. Sensitivity to Fas-mediated apoptosis is null or weak in B-cell non-Hodgkin's lymphomas and is moderately increased by CD40 ligation. British Journal of Cancer 1998; 78: 225–232
  • Plumas J., Jacob M. -C., Chaperot L., Molens J. -P., Sotto J. -J., Bensa J. -C. Tumor B cells from non-Hodgkin's lymphoma are resistant to CD95 (Fas/Apo-1)-mediated apoptosis. Blood 1998; 91: 2875–2885
  • Thornberry N. A., Bull H. G., Calaycay J. R., Chapman K. T., Howard A. D., Kostura M. J., Miller D. K., Molineaux S. M., Weidner J. R., Aunins J., Elliston K. O., Ayala J. M., Casano F. J., Chin J., Ding G. J. F., Egger L. A., Gaffney E. P., Umjuco G., Palyha O. C., Raju S. M., Ralando A. M., Salley J. P., Yamin T. T., Lee T. D., Shivley J. E., Mac-Cross M., Mumford M., Schnidt J. A., Tocci M. J. A novel heterodimeric cysteine protease is required for interleukine-1-β processing in monocytes. Nature 1992; 356: 768–774
  • Budihardjo I., Oliver H., Lutter M., Luo X., Wang X. Biochemical patways of caspase activation during apoptosis. Annual Review In Cell Developmental Biology 1999; 15: 269–290
  • Wang J., Zheng L., Lobito A., Chan F. K.-H., Dale J., Sneller M., Yao X., Puck J. M., Straus S. E., Lenardo M. J. Inherited human caspase 10 mutations underlie defective lymphocyte and dentritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell 1999; 98: 47–58
  • Los M., Wesselborg S., Schulze-Osthoff K. The role of caspases in development, immunity, and apoptotic signal transduction: lessons from knockout mice. Immunity 1999; 10: 629–639
  • Humke E. W., Ni J., Dixit V. M. ERICE, a novel FLICE-activable caspase. Journal of Biological Chemistry 1998; 273: 15702–15707
  • Thornberry N. A., Rano T. A., Peterson E. P., Rasper D. M., Timkey T., Garcia-Calvo M., Houtzager V. M., Nordstrom P. A., Roy S., Vaillancourt J. P., Chapman K. T., Nicholson D. W. A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. Journal of Biological Chemistry 1997; 272: 17907–17911
  • Cheng E. H., Kirsch D. G., Clem R. J., Ravi R. J., Ravi R., Kastan M. B., Bedi A., Ueno K., Hardwick J. M. Conversion of Bcl-2 to a Bax-like death effector by caspases. Science 1997; 278: 1966–1968
  • Clem R. J., Cheng E. H.-Y., Karp C. L., Kirsch D. G., Ueno K., Takahashi A., Kastan M. B., Griffin D. E., Earnshaw W. C., Veliuona M. A., Hardwick J. M. Modulation of cell death by Bel-XL through caspase interaction. Proceedings of the National Academy of Sciences of the United States of America 1998; 95: 554–559
  • Liu X., Zou H., Slaughter C., Wang X. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 1997; 89: 175–184
  • Enari M., Sakahira H., Yokoyama H., Okawa K., Iwamatsu A., Nagata S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 1998; 391: 43–50
  • Li H., Zhu H., Xu C. J., Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 1998; 94: 491–501
  • Lazebnik Y. A., Kaufmann S. H., Desnoyers S., Poirier G. G., Earnshaw W. C. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 1994; 371: 346–347
  • Mashima T., Naito M., Fujita N., Noguehi K., Tsuruo T. Identification of actin as a substrate of ICE and an ICE-like protease and involvement of an ICE-like protease but not ICE in VP-16-induced U937 apoptosis. Biochemical and Biophysical Research Communications 1995; 217: 1185–1192
  • Brancolini C., Benedetti M., Schneider C. EMBO Journal 1995; 14: 5179–5190
  • Martin S. J., O'Brien G. A., Nishioka W. K., McGahon A. J., Mahboubi A., Saido T. C., Green D. R. Proteolysis of fodrin (non-erythroid spectrin) during apoptosis. Journal of Biological Chemistry 1995; 270: 6425–6428
  • Tan X., Wang J. Y. The caspase-RB connection in cell death. Trends in Cell Biology 1998; 8: 116–120
  • Widmann C., Gibson S., Johnson G. L. Caspase-dependent cleavage of signaling proteins during apoptosis. Journal of Biological Chemistry 1998; 273: 7141–7147
  • Casciola-Rosen L., Nicholson D. W., Chong T., Rowan K. R., Thornberry N. A., Miller D. K., Rosen A. Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death. Journal of Experimental Medecine 1996; 183: 1957–1964
  • Wen L. P., Fahrni J. A., Troie S., Guan J. L., Orth K., Rosen G. D. Cleavage of focal adhesion kinase by caspases during apoptosis. Journal of Biological Chemistry 1997; 272: 26056–26061
  • Rudel T., Bokoch G. M. Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2. Science 1997; 276: 1571–1574
  • Walker N. P., Talanian R. V., Brady K. D., Dang L. C., Bump N. J., Ferenz C. R., Franklin S., Ghayur T., Hackett M. C., Hammill L. D. Crystal structure of the cysteine protease interleukin-1β-converting enzyme: a (p20/p10)2 homodimer. Cell 1994; 78: 343–352
  • Cryns V., Yuan J. Proteases to die for. Genes and development 1998; 12: 1551–1570
  • Muzio M., Chinnaiyan A. M., Kischkel F. C., O'Rourke K., Shevchenko A., Ni J., Scaffidi C., Bretz J. D., Zhang M., Gentz R., Mann M., Krammer P. H., Peter M. E., Dixit V. M. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 1996; 85: 817–827
  • Zou H., Henzel W. J., Liu X., Lutschg A., Wang X. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of cas-pase-3. Cell 1997; 90: 405–413
  • Li P., Nijhawan D., Budihardjo I., Srinivasula S. M., Ahmad M., Alnemri E. S., Wang X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997; 91: 479–489
  • Hofman K., Bucher P., Tschopp J. The CARD domain: a new apoptotic signaling motif. Trends in Biochemical Sciences 1997; 22: 155–156
  • Thome M., Schneider P., Hofmann K., Fickenscher H., Meinl E., Neipel E., Mattmann C., Burns K., Bodmer J. L., Schroter M., Scaffidi C., Krammer P. H., Peter M. E., Tschopp J. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 1997; 386: 517–521
  • Djerbi M., Screpanti V., Catrina A. I., Bogen B., Biberfeld P., Grandien A. The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors. Journal of Experimental Medicine 1999; 190: 1025–1031
  • Irmler M., Thome M., Hahne M., Schneider P., Hofmann K., Steiner V., Bodmer J. -L., Schroter M., Burns K., Mattmann C., Rimoldi D., French L. E., Tschopp J. Inhibition of death receptor signals by cellular FLIP. Nature 1997; 388: 190–195
  • Scaffidi C., Fulda S., Srinivasan A., Friesen C., Li F., Tomaselli K. J., Debatin K. M., Krammer P. H., Peter M. E. Two CD95(APO-1/Fas) signaling pathways. EMBO Journal 1998; 17: 1675–1687
  • Yang J., Liu X., Bhalla K., Kim C. N., Ibrado A. M., Cai J., Peng T. I., Jones D. P., Wang X. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 1997; 275: 1129–1132
  • Hu Y., Benedict M. A., Wu D., Inohara N., Nunez G. Bel-XL interacts with Apaf-1 and inhibits Apaf-1 dependent caspase-9 activation. Proceedings of the National Academy of Sciences of the United States of America 1998; 95: 4386–4391
  • Jürgensmeier J. M., Xie Z., Deveraux Q., Ellerby L., Bredesen D., Reed J. C. Bax directly induces release of cytochrome c from isolated mitochondria. Proceedings of the National Academy of Sciences of the United States of America 1998; 95: 4997–5002
  • Roy N., Deveraux Q. L., Takahashi R., Salvesen G. S., Reed J. C. The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO journal 1997; 16: 6914–6925
  • Deveraux Q. L., Takahashi R., Salvesen G. S., Reed J. C. X-linked IAP is a direct inhibitor of cell-death proteases. Nature 1997; 388: 300–304
  • Xerri L., Devilard E., Ayello C., Brousset P., Reed J. C., Emile J. -E., Hassoun J., Parmentier S., Birg F. Cysteine protease CPP32, but not Ich 1-L, is expressed in germinal center B cells and their neoplastic counterparts. Human Pathology 1997; 28: 912–921
  • Krajewski S., Gascoyne R. D., Zapata J. M., Krajewska M., Kitada S., Chhanabhai M., Horsman D., Berean K., Piro L. D., Fugier-Vivier I., Liu Y. -J., Wang H. -G., Reed J. C. Immunolocalization of the ICE/Ced-3-family protease, CPP32 (Caspase-3), in non-Hodgkin's lymphomas, chronic lymphocytic leukemias, and reactive lymph nodes. Blood 1997; 89: 3817–3825
  • Donoghue S., Baden H. S., Lauder I., Sobolewski S., Pringle J. H. Immunohistochemical localization of cas-pase-3 correlates with clinical outcome in B-cell diffuse large-cell Lymphoma. Cancer Research 1999; 59: 5386–5391
  • Xerri L., Carbuccia N., Parc P., Hassoun J., Birg F. Frequent expression of FAS/APO-1 in Hodgkin's disease and anaplastic large cell lymphomas. Histopathology 1995; 27: 235–241
  • Zhao E. G., Song Q., Cross S., Misko L., Lees-Miller S. P., Lavin M. F. Resistance to etoposide-induced apoptosis in a Burkitt's lymphoma cell line. International Journal of Cancer 1998; 77: 755–762
  • Xerri L., Devilard E., Bouabdallah R., Stoppa A. -M., Hassoun J., Birg F. FADD expression and caspase activation in B-cell lymphomas resistant to Fas-mediated apoptosis. British Journal of Haematology 1999; 106: 652–661
  • King D., Pringle J. H., Hutchinson M., Cohen G. M. Processing/activation of caspases, -3 and -7 and -8 but not caspase-2, in the induction of apoptosis in B-chronic lymphocytic leukemia cells. Leukemia 1998; 12: 1553–1560
  • Gutierrez M. I., Cherney B., Hussain A., Mostowski H., Tosato G., Magrath I., Bhatia K. Bax is frequently compromised in Burkitt's lymphomas with irreversible resistance to Fas-induced apoptosis. Cancer Research 1999; 59: 696–703
  • Chlichlia K., Peter M. E., Rocha M., Scaffidi C., Bucur M., Krammer P. H., Schirrmacher V., Umansky V. Caspase activation is required for nitric oxide-mediated, CD95(APO-1/Fas)-dependent and independent apoptosis in human neoplastic lymphoid cells. Blood 1998; 91: 4311–4320
  • Kawabata Y., Hirokawa M., Kitabayashi A., Horiuchi T., Kuroki J., Miura A. B. Defective apoptotic signal transduction pathway downstream of Caspase-3 in human B-lymphoma cells: a novel mechanism of nuclear apoptosis resistance. Blood 1999; 10: 3523–3530
  • Dierlamm J., Baens M., Wlodarska I., Stefanova-Ouzounova M., Hernandez J. M., Hossfeld D. K., De Wolf-Peeters C., Hagemeijer A., Van Den Berghe H., Marynen P. The apoptosis inhibitor gene AP12 and a novel 18q gene, MLT, are recurrently rearranged in the 1(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas. Blood 1999; 93: 3601–3609
  • Ambrosini G., Adida C., Altieri D. C. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nature Medicine 1997; 3: 917–921
  • Zhang Q., Siebert R., Yan M., Hinzmann B., Cui X., Xue L., Rakestraw K. M., Naeve C. W., Beckmann G., Weisenburger D. D., Sanger W. G., Nowotny H., Vesely M., Callet-Bauchu E., Salles G., Dixit V. M., Rosenthal A., Schlegelberger B., Morris S. W. Inactivating mutations and overexpression of BCL 10 a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32). Nature Genetics 1999; 22: 63–68
  • Yan M., Lee J., Schilbach S., Goddard A., Dixit V. mE10, a novel caspase recruitment domain-containing proapoptotic molecule. Journal of Biological Chemistry 1999; 274: 10287–10292
  • Tepper C. G., Seldin M. F. Modulation of caspase-8 and FLICE-inhibitory protein expression as a potential mechanism of Epstein-Barr virus tumorigenesis in Burkitt's lymphoma. Blood 1999; 94: 1727–1737

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.